{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:15:26Z","timestamp":1792613726692,"version":"4.5.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2019.00097","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T04:18:32Z","timestamp":1551413912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Beneficial Effects of GLP-1 Agonist in a Male With Compulsive Food-Related Behavior Associated With Autism"],"prefix":"10.3389","volume":"10","author":[{"given":"Anna","family":"J\u00e4rvinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merja K.","family":"Laine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roope","family":"Tikkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija L.","family":"Castr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s10578-017-0717-0","article-title":"Restricted, repetitive behaviors in autism spectrum disorder and obsessive-compulsive disorder: a comparative review","volume":"48","author":"Jiujias","year":"2017","journal-title":"Child Psychiatry Hum Dev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.euroneuro.2015.12.003","article-title":"Compulsivity in obsessive-compulsive disorder and addictions","volume":"26","author":"Figee","year":"2016","journal-title":"Eur Neuropsychopharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.psc.2006.02.002","article-title":"Compulsive aspects of impulse-control disorders","volume":"29","author":"Grant","year":"2006","journal-title":"Psychiatr Clin North Am."},{"key":"B4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4137\/SART.S39921","article-title":"Autism spectrum disorder and co-occurring substance use disorder - a systematic review","volume":"10","author":"Arnevik","year":"2016","journal-title":"Subst Abuse"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0141703","DOI":"10.1371\/journal.pone.0141703","article-title":"Obsessive-compulsive disorder and autism spectrum disorders: longitudinal and offspring risk","volume":"10","author":"Meier","year":"2015","journal-title":"PLoS ONE"},{"key":"B6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11920-017-0846-y","article-title":"Anxiety disorders and obsessive-compulsive disorder in individuals with autism spectrum disorder","volume":"19","author":"Postorino","year":"2017","journal-title":"Curr Psychiatry Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1176\/appi.ajp.2011.10050764","article-title":"A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders","volume":"169","author":"Hollander","year":"2012","journal-title":"Am J Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1001\/archpsyc.55.7.633","article-title":"A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders","volume":"55","author":"Mcdougle","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13063-016-1266-8","article-title":"Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial","volume":"17","author":"H\u00e4ge","year":"2016","journal-title":"Trials"},{"key":"B10","doi-asserted-by":"publisher","first-page":"E1314","DOI":"10.1210\/jc.2011-0038","article-title":"Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome","volume":"96","author":"Sze","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1507\/endocrj.EJ12-0074","article-title":"The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome","volume":"59","author":"Senda","year":"2012","journal-title":"Endocr J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.2337\/dc13-2575","article-title":"Use of GLP-1 receptor agonists in Prader-Willi Syndrome: report of six cases","volume":"37","author":"Fintini","year":"2014","journal-title":"Diabetes Care"},{"key":"B13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","article-title":"Glucagon-like peptide 1 in health ad disease","volume":"14","author":"Andersen","year":"2018","journal-title":"Nat Rev Endocrinol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"d7771","DOI":"10.1136\/bmj.d7771","article-title":"Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials","volume":"344","author":"Vilsb\u00f8ll","year":"2012","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.physbeh.2011.05.033","article-title":"Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism","volume":"104","author":"Teff","year":"2011","journal-title":"Physiol Behav."},{"key":"B16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/adb.12295","article-title":"The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents","volume":"21","author":"Vallof","year":"2016","journal-title":"Addict Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1007\/s00125-015-3754-x","article-title":"Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes","volume":"58","author":"ten Kulve","year":"2015","journal-title":"Diabetologia."},{"key":"B18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pcd.2017.06.009","article-title":"Effects of incretin-based therapies on neurocognitive function in humans: a systematic review of the literature","volume":"12","author":"Dumbrill","year":"2018","journal-title":"Prim Care Diabetes"},{"key":"B19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnins.2016.00027","article-title":"Striatal circuits as a common node for autism pathophysiology","volume":"10","author":"Fuccillo","year":"2013","journal-title":"Front Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","article-title":"Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain","volume":"4","author":"Cork","year":"2015","journal-title":"Mol Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1172\/JCI97233","article-title":"Discovery, characterization, and clinical development of the glucagon-like peptides","volume":"127","author":"Drucker","year":"2017","journal-title":"J Clin Invest."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00097\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T04:18:33Z","timestamp":1551413913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00097\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":21,"alternative-id":["10.3389\/fpsyt.2019.00097"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2019.00097","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,1]]},"article-number":"97"}}